Takeda’s Entyvio (vedolizumab) Receives the MHLW Approval for the Maintenance Treatment of Moderate to Severe Ulcerative Colitis
Shots: The MHLW has approved the use of Entyvio (SC) as maintenance therapy for th...
Regeneron’s Libtayo (cemiplimab) Receive EC’s Approval as 1L Treatment of Advanced PD-L1 Positive Non-Small Cell Lung Cancer
Shots: The EC has approved Libtayo in combination with Pt-based CT for adult patie...
AstraZeneca’s Tezspire (tezepelumab) Receives NICE Recommendation as an Add-On Treatment for Severe Uncontrolled Asthma
Shots: The NICE has issued final draft guidance recommending Tezspire for use with...
BMS’ Sotyktu (deucravacitinib) Receives EC’s Approval for the Treatment of Plaque Psoriasis
Shots: The approval was based on the P-III trials (POETYK PSO-1 & 2) evaluatin...
Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) Receives the MHLW’s Approval as the First HER2 Directed Therapy for HER2 Low Met...
Shots: The MHLW has approved Enhertu (HER2 directed ADC) for HER2 low (IHC 1+ or I...
Pharming’s Joenja (leniolisib) Receives the US FDA’s Approval as First Treatment for Activated Phosphoinositide 3-Kinase Delta Syn...
Shots: The US FDA has approved Joenja (selective PI3Kδ inhibitor) for APDS i...
